02611nam 2200613 a 450 991045724660332120200520144314.01-283-21345-197866132134570-309-21222-7(CKB)2550000000043073(EBL)3378800(SSID)ssj0000537170(PQKBManifestationID)11352570(PQKBTitleCode)TC0000537170(PQKBWorkID)10553842(PQKB)11052430(MiAaPQ)EBC3378800(Au-PeEL)EBL3378800(CaPaEBR)ebr10488621(CaONFJC)MIL321345(OCoLC)923283605(EXLCZ)99255000000004307320110827d2011 uy 0engurcn|||||||||txtccrGlutamate-related biomarkers in drug development for disorders of the nervous system[electronic resource] workshop summary /Diana E. Pankevich, Miriam Davis, and Bruce M. Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board of Population Health and Public Health Practice, Institute of Medicine of the National AcademiesWashington, D.C. National Academies Press20111 online resource (74 p.)Description based upon print version of record.0-309-21221-9 Includes bibliographical references and index.""Front Matter""; ""Reviewers""; ""Contents""; ""1 Introduction""; ""2 Overview of the Glutamatergic System""; ""3 Glutamate Biomarkers""; ""4 Treatment Implications of Biomarkers""; ""5 Challenges and Opportunities""; ""Appendix A: References""; ""Appendix B: Registered Attendees""; ""Appendix C: Agenda""Glutamic acidPharmacokineticsCentral nervous systemDiseasesElectronic books.Glutamic acidPharmacokinetics.Central nervous systemDiseases.616.8061Pankevich Diana E856947Davis Miriam856948Altevogt Bruce M856949Institute of Medicine (U.S.).Forum on Neuroscience and Nervous System Disorders.Institute of Medicine (U.S.).Board of Population Health and Public Health Practice.MiAaPQMiAaPQMiAaPQBOOK9910457246603321Glutamate-related biomarkers in drug development for disorders of the nervous system1913742UNINA